These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 37852045)
1. Association of APOE-ε4 and GAP-43-related presynaptic loss with β-amyloid, tau, neurodegeneration, and cognitive decline. Lan G; Du J; Chen X; Wang Q; ; Han Y; Guo T Neurobiol Aging; 2023 Dec; 132():209-219. PubMed ID: 37852045 [TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease. Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O; JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367 [TBL] [Abstract][Full Text] [Related]
3. Multiple Effect of APOE Genotype on Clinical and Neuroimaging Biomarkers Across Alzheimer's Disease Spectrum. Liu Y; Tan L; Wang HF; Liu Y; Hao XK; Tan CC; Jiang T; Liu B; Zhang DQ; Yu JT; Mol Neurobiol; 2016 Sep; 53(7):4539-47. PubMed ID: 26298664 [TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein E epsilon4 does not modulate amyloid-β-associated neurodegeneration in preclinical Alzheimer disease. Desikan RS; McEvoy LK; Holland D; Thompson WK; Brewer JB; Aisen PS; Andreassen OA; Hyman BT; Sperling RA; Dale AM; AJNR Am J Neuroradiol; 2013 Mar; 34(3):505-10. PubMed ID: 22976236 [TBL] [Abstract][Full Text] [Related]
5. Association of Presynaptic Loss with Alzheimer's Disease and Cognitive Decline. Lan G; Cai Y; Li A; Liu Z; Ma S; Guo T; Ann Neurol; 2022 Dec; 92(6):1001-1015. PubMed ID: 36056679 [TBL] [Abstract][Full Text] [Related]
9. The Role of Apolipoprotein E ε4 in Early and Late Mild Cognitive Impairment. Luo Y; Tan L; Therriault J; Zhang H; Gao Y; Eur Neurol; 2021; 84(6):472-480. PubMed ID: 34340229 [TBL] [Abstract][Full Text] [Related]
10. Effect of apolipoprotein E on biomarkers of amyloid load and neuronal pathology in Alzheimer disease. Vemuri P; Wiste HJ; Weigand SD; Knopman DS; Shaw LM; Trojanowski JQ; Aisen PS; Weiner M; Petersen RC; Jack CR; Ann Neurol; 2010 Mar; 67(3):308-16. PubMed ID: 20373342 [TBL] [Abstract][Full Text] [Related]
11. An increased rate of longitudinal cognitive decline is observed in Parkinson's disease patients with low CSF Aß42 and an APOE ε4 allele. Shahid M; Kim J; Leaver K; Hendershott T; Zhu D; Cholerton B; Henderson VW; Tian L; Poston KL Neurobiol Dis; 2019 Jul; 127():278-286. PubMed ID: 30826425 [TBL] [Abstract][Full Text] [Related]
13. Interactions between apolipoprotein E, sex, and amyloid-beta on cerebrospinal fluid p-tau levels in the European prevention of Alzheimer's dementia longitudinal cohort study (EPAD LCS). Saunders TS; Jenkins N; Blennow K; Ritchie C; Muniz-Terrera G EBioMedicine; 2022 Sep; 83():104241. PubMed ID: 36041266 [TBL] [Abstract][Full Text] [Related]